Can testosterone therapy help men and women manage type 2 diabetes?

Testosterone therapy has been studied for its potential metabolic effects in people with type 2 diabetes, particularly in those with clinically confirmed hypogonadism. In this episode, we explain what the evidence shows and how treatment is assessed in Europe.

In this episode, we cover:

• What type 2 diabetes is (insulin resistance with progressive beta-cell dysfunction)

• What testosterone does in the body (muscle mass, fat distribution, insulin sensitivity)

• The link between low testosterone and metabolic syndrome

• Evidence on HbA1c, body composition, and insulin resistance

• Differences between male hypogonadism and female androgen therapy

• Risks and contraindications of testosterone treatment

• Required blood tests before and during therapy

• Situations where prescription requests may be declined

Doctors assess confirmed hormone deficiency through laboratory testing, symptoms, cardiovascular risk, prostate health (in men), and overall metabolic profile before considering therapy. Testosterone is not a primary treatment for type 2 diabetes and is not appropriate without documented deficiency. Some patients require in-person examination or specialist referral.

This episode reflects how hormonal and metabolic conditions are evaluated within European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/how-testosterone-therapy-can-help-men-and-women-manage-type-2-diabetes